Inato grabs $14 mn
Paris-based Inato, a platform that helps biopharmaceutical companies increase the pool of available patients engaged in clinical trials, has raised $14 million in Series A financing.
Paris-based Inato, a platform that helps biopharmaceutical companies increase the pool of available patients engaged in clinical trials, has raised $14 million in Series A financing.
Copyright PEI Media
Not for publication, email or dissemination